Hema Remedies Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 10 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 25.19 Cr
- Revenue Growth 169.82%
- Profit Growth 80.08%
- Ebitda 1105.15%
- Net Worth -3.97%
- Total Assets 5.74%
About Hema Remedies
Hema Remedies Private Limited (HRPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 17 September 2014 and has a history of Ten years and four months. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹25.19 Cr.
Abhilash Shah and Chirag Dadhania serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24100GJ2014PTC080815
-
Company No.
080815
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Sep 2014
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Hema Remedies?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhilash Shah
|
Director | 02-Jul-2018 | Current |
|
Chirag Dadhania
|
Director | 16-Mar-2015 | Current |
Financial Performance of Hema Remedies.
Hema Remedies Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 169.82% increase. The company also saw a substantial improvement in profitability, with a 80.08% increase in profit. The company's net worth dipped by a decrease of 3.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hema Remedies?
In 2022, Hema Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Hema Laboratories Pvt LtdAbhilash Shah is a mutual person
-
Shaurya Projects LlpAbhilash Shah is a mutual person
-
Hema Healthcare Private Limited
Abhilash Shah is a mutual person
Charges (Loans)
₹251.88 M
₹0
Charges Breakdown by Lending Institutions
- Yes Bank Limited : 25.19 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Apr 2015 | Yes Bank Limited | ₹12.59 Cr | Open |
| 20 Mar 2015 | Yes Bank Limited | ₹12.59 Cr | Open |
How Many Employees Work at Hema Remedies?
Hema Remedies has a workforce of 17 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hema Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hema Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
